Archive/A Clinical Score to Identify Individuals at High Risk of Pancreatic Cancer in the General Population
A Clinical Score to Identify Individuals at High Risk of Pancreatic Cancer in the General Population
Hyo Jeong Lee, Ji Seon Oh, Sehee Kim et al.
29 juillet 2026
en

Abstract

Background/Objectives: Early detection of pancreatic cancer (PC) remains challenging due to the lack of effective screening tools. We aimed to develop a clinically applicable model to identify individuals at high risk of PC using routine health check-up data. Methods: In a 1:4 matched case–control study (111 cases and 439 controls) using data collected between 2010 and 2018, PC cases were defined as individuals diagnosed with PC within 2 years of a health check-up. A model was developed using conditional logistic regression and validated in an independent cohort of 52,043 individuals (40 PC cases; 2019–2021). Results: Five risk factors were identified: carbohydrate antigen 19-9 ≥ 39 U/mL, hemoglobin A1c ≥ 6.5%, alkaline phosphatase > 110 IU/L, weight loss ≥ 5%, and dyspepsia. A 12-point risk scoring system was constructed, with an area under the curve of 0.784 in the development and 0.841 in the validation cohort. At a threshold of ≥5, the high-risk group had a significantly higher 2-year incidence of PC than the low-risk group (2.56% vs. 0.047%; p < 0.001), a 54.76-fold risk enrichment, with a negative predictive value of 99.95% and a number-needed-to-follow of 39. Conclusions: This simple, validated model effectively stratifies short-term PC risk using routine data, potentially facilitating targeted surveillance in the general population.

IPC Classification

G06A61

Keywords

clinicalscoreidentifyindividualshighriskpancreaticcancergeneralpopulationdiagnosticsbackgroundobjectivesearlydetectionremainschallenginglackeffectivescreeningtoolsaimeddevelopclinically
Citer cette publication

€ 4.00